Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial

NCT00190957 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00190957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
January 31, 2006
Enrollment
140
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, comorbid alcohol abuse